معرفی
Marc C. Smaldone, MD, MSHP, FACS, is a Professor of Urology and Director of Surgical Quality at Fox Chase Cancer Center, part of Temple University Health System. He specializes in urologic oncology, focusing on robotic/laparoscopic surgery for cancers of the kidney, bladder, prostate, and adrenal glands. His research emphasizes quality of care, health disparities, and surgical outcomes in oncology.
Education includes:
- Fellowship in Urologic Oncology at Fox Chase Cancer Center
- Residency at University of Pittsburgh School of Medicine
- MS in Health Policy Research from University of Pennsylvania
- MD from SUNY Stony Brook School of Medicine
Research interests span comparative effectiveness, risk assessment, access disparities, and innovative surgical techniques for genitourinary cancers. His work consistently addresses quality improvement in cancer care delivery systems.
Publications demonstrate strong focus on evidence-based surgical oncology, with recent articles exploring risk-stratified cancer management, racial disparities in treatment, and real-world outcomes data across urologic malignancies. Recurring themes include surgical quality metrics, minimally invasive techniques, and personalized treatment approaches.
Awards and honors:
- Philadelphia Magazine Top Doctor (2023-2024)
- Main Line Today Top Doctor (2018-2019)
- Fellow of the American College of Surgeons
Leads multidisciplinary teams at Fox Chase's Genitourinary Cancer Patient Care program, collaborating with medical and radiation oncology specialists. Current research includes NIH-funded trials on perioperative risk management and bladder cancer therapy optimization.
